Literature DB >> 23563860

Age-related alteration in cerebral blood flow and energy failure is correlated with cognitive impairment in the senescence-accelerated prone mouse strain 8 (SAMP8).

Xuezhu Zhang1, Guomin Li, Lin Guo, Kun Nie, Yujie Jia, Lan Zhao, Jianchun Yu.   

Abstract

Cerebrovascular dysfunction is an early pathogenic event in Alzheimer's disease (AD) and plays a key role in the disease process. Cerebral hypoperfusion, brain glucose hypometabolism and disrupted blood-brain barrier (BBB) integrity contributed to the onset and progression of AD. However, the relationships between the age-related cognitive impairment and cerebral blood flow (CBF), energy metabolism and BBB have not been clearly explained. In this study, we investigated the cognitive function, CBF, BBB damage and expression level of glucose transporter (GLUT) 1 and 3 of senescence-accelerated mouse prone 8 (SAMP8), and the correlations between each of them were analyzed. When compared with SAMR1 (senescence-accelerated mouse resistant 1), the cognitive abilities of SAMP8 were damaged apparently even at 4 months of age, showing up a slower and more capricious acquisition in Morris water maze tasks. In both SAMP8 and SAMR1, reduced CBF and increased BBB leakage were observed with increasing age, but an earlier and more severe impairment was detected in SAMP8. In addition, alterations of GLUT1 and GLUT3 protein expression in cortex and hippocampus were more prominent in SAMP8. Correlation analysis demonstrated that the increased escape latency was correlated negatively with CBF and expression of glucose transporters; and positively with BBB permeability in the hippocampus. These results suggested that CBF, BBB integrity, the expression of GLUT1 and GLUT3 were significantly affected by age and strain, which were also closely associated with cognitive ability. The alteration in CBF and energy failure induced by aging and vascular insults resulted in cognitive decline in SAMP8.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23563860     DOI: 10.1007/s10072-013-1407-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  30 in total

1.  Alzheimer's disease and Alzheimer's dementia: distinct but overlapping entities.

Authors:  John P Blass
Journal:  Neurobiol Aging       Date:  2002 Nov-Dec       Impact factor: 4.673

2.  Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer's disease.

Authors:  Lisa Mosconi; Wai H Tsui; Henry Rusinek; Susan De Santi; Yi Li; Gene-Jack Wang; Alberto Pupi; Joanna Fowler; Mony J de Leon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-04-04       Impact factor: 9.236

3.  Hippocampal hypometabolism predicts cognitive decline from normal aging.

Authors:  Lisa Mosconi; Susan De Santi; Juan Li; Wai Hon Tsui; Yi Li; Madhu Boppana; Eugene Laska; Henry Rusinek; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2007-01-11       Impact factor: 4.673

4.  The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization.

Authors:  B Desgranges; J C Baron; V de la Sayette; M C Petit-Taboué; K Benali; B Landeau; B Lechevalier; F Eustache
Journal:  Brain       Date:  1998-04       Impact factor: 13.501

5.  Vascular factors in Alzheimer's disease.

Authors:  Raj N Kalaria
Journal:  Int Psychogeriatr       Date:  2003       Impact factor: 3.878

6.  Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.

Authors:  G L Bowman; J A Kaye; M Moore; D Waichunas; N E Carlson; J F Quinn
Journal:  Neurology       Date:  2007-05-22       Impact factor: 9.910

7.  Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.

Authors:  Aoife Hunt; Peter Schönknecht; Marcus Henze; Ulrich Seidl; Uwe Haberkorn; Johannes Schröder
Journal:  Psychiatry Res       Date:  2007-05-23       Impact factor: 3.222

Review 8.  Pathophysiology of neuronal energy crisis in Alzheimer's disease.

Authors:  Jack C de la Torre
Journal:  Neurodegener Dis       Date:  2008-03-06       Impact factor: 2.977

9.  Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  A Heyman; G G Fillenbaum; K A Welsh-Bohmer; M Gearing; S S Mirra; R C Mohs; B L Peterson; C F Pieper
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

10.  Diminished glucose transport in Alzheimer's disease: dynamic PET studies.

Authors:  W J Jagust; J P Seab; R H Huesman; P E Valk; C A Mathis; B R Reed; P G Coxson; T F Budinger
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

View more
  17 in total

1.  Decline in Sirtuin-1 expression and activity plays a critical role in blood-brain barrier permeability in aging.

Authors:  Svetlana M Stamatovic; Gabriela Martinez-Revollar; Anna Hu; Jennifer Choi; Richard F Keep; Anuska V Andjelkovic
Journal:  Neurobiol Dis       Date:  2018-09-06       Impact factor: 5.996

Review 2.  Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.

Authors:  Cátia Janota; Cynthia A Lemere; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2015-07-05       Impact factor: 5.590

3.  The Antiepileptic Ketogenic Diet Alters Hippocampal Transporter Levels and Reduces Adiposity in Aged Rats.

Authors:  Abbi R Hernandez; Caesar M Hernandez; Keila T Campos; Leah M Truckenbrod; Yasemin Sakarya; Joseph A McQuail; Christy S Carter; Jennifer L Bizon; Andrew P Maurer; Sara N Burke
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-03-14       Impact factor: 6.053

4.  G-quadruplexes Stabilization Upregulates CCN1 and Accelerates Aging in Cultured Cerebral Endothelial Cells.

Authors:  Brian Noh; Maria P Blasco-Conesa; Yun-Ju Lai; Bhanu Priya Ganesh; Akihiko Urayama; Ines Moreno-Gonzalez; Sean P Marrelli; Louise D McCullough; Jose Felix Moruno-Manchon
Journal:  Front Aging       Date:  2022-01-12

5.  Dietary Protein Source Influences Brain Inflammation and Memory in a Male Senescence-Accelerated Mouse Model of Dementia.

Authors:  Sabrina Petralla; Cristina Parenti; Valentina Ravaioli; Irene Fancello; Francesca Massenzio; Marco Virgili; Barbara Monti; Emiliano Pena-Altamira
Journal:  Mol Neurobiol       Date:  2020-11-09       Impact factor: 5.590

Review 6.  Age-related immune alterations and cerebrovascular inflammation.

Authors:  Carson E Finger; Ines Moreno-Gonzalez; Antonia Gutierrez; Jose Felix Moruno-Manchon; Louise D McCullough
Journal:  Mol Psychiatry       Date:  2021-10-28       Impact factor: 13.437

7.  Safety and pharmacological characterization of the molecular tweezer CLR01 - a broad-spectrum inhibitor of amyloid proteins' toxicity.

Authors:  Aida Attar; Wai-Ting Coco Chan; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan
Journal:  BMC Pharmacol Toxicol       Date:  2014-04-16       Impact factor: 2.483

8.  The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.

Authors:  Henrik H Hansen; Katrine Fabricius; Pernille Barkholt; Michael L Niehoff; John E Morley; Jacob Jelsing; Charles Pyke; Lotte Bjerre Knudsen; Susan A Farr; Niels Vrang
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 9.  Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease.

Authors:  Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-22       Impact factor: 6.200

Review 10.  Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.

Authors:  Christian Griñán-Ferré; Rubén Corpas; Dolors Puigoriol-Illamola; Verónica Palomera-Ávalos; Coral Sanfeliu; Mercè Pallàs
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.